What Is the Most Important Thing to Do to Defend Against DEA, OIG, FBI, and IRS Opioid Fraud Investigations

Retain counsel experienced in federal healthcare fraud defense before speaking with any investigator, producing any document, and before making any decision about the investigation’s direction.

That sentence is the answer. The rest of this article explains why each clause in it matters.

Multi-agency opioid fraud investigations are among the most complex and consequential proceedings in federal law enforcement. The DEA is examining the controlled substance prescribing under the Controlled Substances Act. The OIG is examining the billing to Medicare and Medicaid under the False Claims Act. The FBI may be examining the financial transactions under the wire fraud and money laundering statutes. The IRS Criminal Investigation division may be examining the unreported income generated by cash-intensive prescribing operations. Each agency has independent investigative authority, its own subpoena power, and its own pathway to charging the same conduct under different statutes. The practitioner who treats this as a single proceeding addressable through a single response strategy has misjudged the terrain.

Why the Sequencing Matters

The most important decision in a multi-agency opioid fraud investigation is not what to say to investigators. It is whether to say anything at all, and in what forum, under what conditions, and with what protections in place. That decision cannot be made rationally without knowing what the government already has, what status the practitioner holds in each investigation, and what the realistic range of outcomes is given the evidence assembled to date. None of that information is available without counsel’s engagement.

Practitioners who speak to investigators before retaining counsel make that decision from a position of maximum ignorance. They do not know which of the agencies they are speaking to has more information than the others. They do not know which statements will reach each of the parallel proceedings through the information-sharing channels that connect the agencies. They do not know whether the interview is a preliminary fact-gathering exercise or a late-stage confirmation of a theory the government has already formed. Every answer given from that position of ignorance is an answer given without understanding its consequences.

The Preservation Obligation Begins Immediately

The moment a practitioner becomes aware that any of these agencies is investigating their practice, the obligation to preserve all potentially relevant records attaches. That obligation encompasses medical records, prescription records, billing records, financial records, electronic communications, and any other document that a reasonable person in the practitioner’s position would understand to be relevant to the investigation. The obligation is not limited to records that are favorable to the practitioner’s position.

Records destroyed after a practitioner becomes aware of an investigation, even pursuant to a pre-existing document retention policy, can constitute obstruction of justice. The obstruction charge that results from document destruction in the face of a known investigation is independent of the underlying prescribing conduct and may carry a more severe guidelines calculation than the conduct that generated the investigation. Preservation is not optional, and it does not require waiting for a formal notice to be served.

Coordinating Across All Agencies

The defense of a multi-agency opioid fraud investigation requires counsel who understands the interaction among the DEA’s administrative proceedings, the criminal investigation, the OIG’s civil investigation, and the IRS’s financial investigation. A response to the DEA’s administrative subpoena that produces documents affecting the OIG’s False Claims Act calculation, that provides the IRS with income figures it had not yet established, or that gives the criminal investigation evidence it was still developing has served four proceedings without being designed to serve any of them well.

The coordination of the defense across all four dimensions of the investigation is the work that experienced federal healthcare fraud counsel performs from the first engagement. It requires an understanding of each agency’s legal authority, each investigation’s current state, and the interaction among the proceedings at every stage of their development. The practitioner who retains counsel after each agency has made its first contact, rather than before any of them have, has inherited a situation that counsel must reconstruct rather than build from the beginning.

DEFENSE TEAM SPOTLIGHT

Todd Spodek

Lead Attorney & Founder

Featured on Netflix's "Inventing Anna," Todd Spodek brings decades of high-stakes criminal defense experience. His aggressive approach has secured dismissals and acquittals in cases others deemed unwinnable.

NY Bar Admitted Multi-State Licensed Federal Courts

Meet the Full Team

The practitioner who retains counsel on the day they become aware that any government agency is examining their practice is the practitioner who retains counsel at the moment that still produces the most options. Every day after that moment is a day during which a decision may be made, or not made, that affects the outcome. The most important thing to do is the first thing to do, and the first thing is to retain counsel.

Legal Scenario: What Would You Do?

Scenario

Federal agents execute a search warrant at your medical practice, seizing patient records and prescription logs.

Can they take patient records without patient consent?

Attorney's Answer

A valid federal search warrant overrides HIPAA privacy protections. However, the warrant must be properly scoped. An attorney can challenge overly broad warrants and move to suppress improperly seized evidence.

This is general information only. Contact us for advice specific to your situation.

The Consultation That Begins Everything

The initial consultation with experienced federal healthcare fraud defense counsel is the proceeding in which the investigation is first mapped from the defense’s perspective. The practitioner describes what they know about each agency’s interest, what contacts have occurred, what documents have been requested, and what the prescribing practice looked like during the period under scrutiny. Counsel assesses the strength of the clinical documentation, identifies the legal theories the government is likely pursuing, evaluates the cooperation options that may be available, and develops a preliminary strategy for managing each dimension of the investigation.

That consultation is protected by the attorney-client privilege. It is the first protected space in which the practitioner can describe their situation fully and receive advice that reflects the complete picture. No prior communication with any investigator, no production of any record, and no decision about the investigation’s direction should precede it.